Sanara MedTech Inc. - 10-Q Filing

Sanara MedTech Inc. reports Q3 2026 financial results including details on convertible loan agreements and segment performance.

SEC EDGAR ·

Tickers: $SMTI

Read the full article at SEC EDGAR

More Regulatory news